SICHUAN BENEPURE PHARMACEUTICAL CO.,LTD – Trademark Portfolio

Entity Type: 99

SICHUAN BENEPURE PHARMACEUTICAL CO.,LTD holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include BENEPURE. The owner is based in CHENGDU, SICHUAN.

1501 RM., 15/F, UNIT 4, 1 BLDG.

No.99, JIRUI 3 RD., GAOXIN DIST.

CHENGDU, SICHUAN 610095 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SICHUAN BENEPURE PHARMACEUTICAL CO.,LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SICHUAN BENEPURE PHARMACEUTICAL CO.,LTD have?

SICHUAN BENEPURE PHARMACEUTICAL CO.,LTD has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does SICHUAN BENEPURE PHARMACEUTICAL CO.,LTD file in?

SICHUAN BENEPURE PHARMACEUTICAL CO.,LTD files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SICHUAN BENEPURE PHARMACEUTICAL CO.,LTD's most well-known trademarks?

SICHUAN BENEPURE PHARMACEUTICAL CO.,LTD's registered trademark portfolio includes well-known marks such as BENEPURE. These are among 1 currently registered trademark in the portfolio.

What is SICHUAN BENEPURE PHARMACEUTICAL CO.,LTD's trademark registration success rate?

SICHUAN BENEPURE PHARMACEUTICAL CO.,LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.